JOINT FILER AGREEMENTJoint Filer Agreement • June 3rd, 2022 • Mak Capital One LLC • Services-computer integrated systems design
The undersigned hereby agree that the statement on Schedule 13D with respect to the Common Stock of Agilysys, Inc. dated as of July 1, 2008 and amended through the date hereof is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Exhibit 2 JOINT FILER AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including...Joint Filer Agreement • January 10th, 2005 • Far East Energy Corp • Crude petroleum & natural gas
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any amendments thereto) with respect to the common stock, par value $0.001 per share, of Far East Energy Corporation, a Nevada corporation. The undersigned further consent and agree to the inclusion of this agreement as an exhibit to such Schedule 13D. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILER AGREEMENTJoint Filer Agreement • August 18th, 2020 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that a single Schedule 13D, or any amendment thereto, relating to the equity securities of CASI Pharmaceuticals, Inc., a Delaware corporation, shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as Exhibit 99.1 to such Schedule 13D.
Joint Filer AgreementJoint Filer Agreement • February 11th, 2008 • TradeLink Securities LLC • Miscellaneous food preparations & kindred products
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • February 16th, 2021 • Valor IV Pharma Holdings, LLC • Pharmaceutical preparations
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • February 14th, 2024 • Cvf, LLC • Surgical & medical instruments & apparatus
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • February 10th, 2022 • Valor IV Pharma Holdings, LLC • Pharmaceutical preparations
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G/A, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G/A shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • February 14th, 2024 • Blatherwick Nell M. • Investment advice
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • February 9th, 2021 • CVF 2018 LLC • Pharmaceutical preparations
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • February 10th, 2022 • CVF 2018 LLC • Pharmaceutical preparations
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G/A, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G/A shall also be filed on behalf of each of them.
JOINT FILER AGREEMENTJoint Filer Agreement • April 11th, 2019 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that a single Schedule 13D, or any amendment thereto, relating to the equity securities of CASI Pharmaceuticals, Inc., a Delaware corporation, shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as Exhibit 99.1 to such Schedule 13D.
JOINT FILER AGREEMENTJoint Filer Agreement • February 15th, 2019 • Mak Capital One LLC • Services-computer integrated systems design
The undersigned hereby agree that the statement on Schedule 13D with respect to the Common Stock of Agilysys, Inc. dated as of July 1, 2008 and amended through the date hereof is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Joint Filer AgreementJoint Filer Agreement • February 13th, 2023 • Valor IV Pharma Holdings, LLC • Pharmaceutical preparations
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G/A, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G/A shall also be filed on behalf of each of them.
JOINT FILER AGREEMENTJoint Filer Agreement • December 23rd, 2005 • Parallel Technologies Inc • Blank checks
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including any amendments thereto) with respect to the common stock, par value $.006 per share, of Parallel Technologies, Inc., a Nevada corporation. The undersigned further consent and agree to the inclusion of this agreement as an exhibit to such Schedule 13D. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILER AGREEMENTJoint Filer Agreement • December 23rd, 2005 • Ocm Principal Opportunities Fund L P • Pharmaceutical preparations
Each of the undersigned acknowledges and agrees that the foregoing statement on Form 4 is filed on behalf of the undersigned and that any subsequent amendments to this statement on Form 4 shall be filed on behalf of the undersigned without the necessity of filing additional joint acquisition statements. Each of the undersigned acknowledges that it shall be responsible for the timely filing of any such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
JOINT FILER AGREEMENTJoint Filer Agreement • May 14th, 2018 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that a single Schedule 13D, or any amendment thereto, relating to the equity securities of CASI Pharmaceuticals, Inc., a Delaware corporation, shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as Exhibit 99.1 to such Schedule 13D.
Joint Filer AgreementJoint Filer Agreement • November 7th, 2024 • Cvf, LLC • Surgical & medical instruments & apparatus
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • November 14th, 2024 • Valor Sonder Holdings, LLC • Hotels, rooming houses, camps & other lodging places
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G/A, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G/A shall also be filed on behalf of each of them.
JOINT FILER AGREEMENTJoint Filer Agreement • September 26th, 2014 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that a single Schedule 13D, or any amendment thereto, relating to the equity securities of CASI Pharmaceuticals, Inc., a Delaware corporation, shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as Exhibit 99.1 to such Schedule 13D.
Joint Filer AgreementJoint Filer Agreement • February 13th, 2024 • Valor IV Pharma Holdings, LLC • Pharmaceutical preparations
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G/A, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G/A shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • February 16th, 2021 • Valor Management LLC • Services-prepackaged software
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • February 13th, 2023 • Valor Equity Associates IV L.P. • Motorcycles, bicycles & parts
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • February 10th, 2022 • Valor Equity Associates IV L.P. • Motorcycles, bicycles & parts
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • February 11th, 2008 • TradeLink Securities LLC • Services-management consulting services
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
Joint Filer AgreementJoint Filer Agreement • May 31st, 2005 • Galloway Scott • Retail-miscellaneous shopping goods stores
This Joint Filer Agreement relates to the Schedule 13D, as amended, filed on behalf of the Section 13D “group” consisting of Scott Galloway, R. Ian Chaplin, Martin McClanan, Michael L. Meyer (the “Original Members”) and the undersignedshares of common stock, par value $0.01, of RedEnvelope, Inc. beneficially owned by the undersigned. The undersigned are members of the Section 13 “group” that file and any future amendments thereto executed by each or any of us shall be jointly filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended.
Joint Filer AgreementJoint Filer Agreement • February 14th, 2023 • Blatherwick Nell M. • Investment advice
The undersigned hereby agree and acknowledge that the statement containing the information required by Schedule 13G, to which this agreement is attached as an exhibit, is filed on behalf of each of them, and any amendments or supplements to the Schedule 13G shall also be filed on behalf of each of them.
